What was the primary driver of the significant increase in Net Earnings and Diluted EPS for the quarter?

The significant increase in Net Earnings and Diluted EPS for the three months ended December 31, 2024, was largely due to the absence of a $1.3 billion ($1.0 billion after tax) non-cash impairment charge on the Gillette intangible asset that occurred in the prior year period. While reported net earnings increased substantially, the company's core EPS, which excludes such charges, provides a better view of ongoing operational performance, showing a more modest but positive increase.

How did the different business segments perform?

The Health Care and Baby, Feminine & Family Care segments demonstrated steady growth. The Fabric & Home Care segment saw modest sales increases. The Beauty segment experienced mixed results, with strong growth in Personal Care but declines in Hair Care and Skin Care, partly attributed to market contraction in specific regions and divestitures. Grooming showed slight sales growth.

What is the company's outlook on its financial health and cash generation?

Procter & Gamble reported strong operating cash flow of $9.1 billion for the six months ended December 31, 2024. The company maintains a healthy liquidity position and expects to continue supporting its short-term needs through cash generated from operations. It also has access to credit facilities and maintains strong debt ratings, enabling it to refinance debt favorably.

Are there any significant risks or uncertainties mentioned in the filing?

The filing highlights several risks, including global economic volatility, foreign currency fluctuations, commodity and supply chain cost pressures, and changes in government policies. The company also notes potential impacts from geopolitical tensions and the ongoing management of its restructuring program, particularly in certain Enterprise Markets.

PG 10-Q Quarterly Report Q2 FY2025 — Revenue, Net Income, EPS

Summary

Procter & Gamble Co. (PG) reported solid results for the second quarter of fiscal year 2025, demonstrating continued resilience and growth. Net sales increased by 2% to $21.9 billion for the three months ended December 31, 2024, driven by a combination of unit volume and favorable product mix. For the six-month period, net sales grew 1% to $43.6 billion. Diluted Earnings Per Share (EPS) saw a significant increase of 34% to $1.88 for the quarter, largely influenced by the absence of a prior year intangible asset impairment charge. The company's core EPS, which excludes certain charges, also showed growth, increasing by 2% for the quarter and 4% for the six-month period, reflecting underlying operational strength. Key operational highlights include continued strength in the Health Care and Baby, Feminine & Family Care segments, with notable growth in Personal Care within the Beauty segment. The company also reported strong operating cash flow of $9.1 billion for the six-month period, underscoring its robust cash generation capabilities. P&G continues to focus on productivity improvements and strategic investments, while also managing currency fluctuations and commodity cost pressures. The company reaffirmed its commitment to returning value to shareholders through dividends and share repurchases, signaling confidence in its ongoing performance and future outlook.

Financial Highlights

53 data points

Beta

Revenue

$21.88B

0.5% Gross Margin

Net Income

$4.63B

0.2% Net Margin

EPS (Diluted)

$1.88

Total Assets

$122.64B

Cash & Equivalents

$10.23B

Free Cash Flow

$3.90B

Financial Statements

Beta

Revenue	$21.88B
Cost of Revenue	$10.42B
Gross Profit	$11.46B
SG&A Expenses	$5.72B
Operating Income	$5.74B
Net Income	$4.63B
EPS (Basic)	$1.94
EPS (Diluted)	$1.88
Shares Outstanding (Basic)	2.35B
Shares Outstanding (Diluted)	2.46B

Key Highlights

1Net sales increased 2% to $21.9 billion for the three months ended December 31, 2024, and 1% to $43.6 billion for the six months ended December 31, 2024.
2Diluted EPS rose 34% to $1.88 for the quarter, benefiting from the lapping of a prior year intangible asset impairment charge.
3Core EPS (excluding specific charges) increased 2% for the quarter and 4% for the six-month period, indicating underlying operational performance.
4Health Care and Baby, Feminine & Family Care segments showed consistent growth, with the Beauty segment's Personal Care sub-segment experiencing double-digit sales growth.
5Operating cash flow was strong at $9.1 billion for the six months ended December 31, 2024.
6The company maintained a focus on productivity savings and managed cost pressures from commodities and transportation.
7Shareholder returns remained a priority, with significant treasury stock purchases and ongoing dividend payments.

PROCTER & GAMBLE Co Quarterly Report for Q2 Ended Dec 31, 2024

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions